MedTrace Logo

Community Clinic Model to Improve Early Detection of Breast and Cervical Cancers in Kenya

NCT06572774 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5400

Last updated 2025-11-24

No results posted yet for this study

Summary

Kenya has a high incidence of breast and cervical cancers, and most women are diagnosed with late-stage disease. The investigators will conduct a study to assess the effectiveness and cost-effectiveness of strategies to increase the uptake of cancer screening and completion of recommended diagnostic and treatment services. The findings can be used to design optimal approaches and plan investments in infrastructure to scale up implementation of breast and cervical cancer screening.

Conditions

Interventions

BEHAVIORAL

C3Link Strategies

Education sessions and community liaison support to link to services

Sponsors & Collaborators

  • Kenya Medical Research Institute

    collaborator OTHER

  • RTI International

    collaborator OTHER

  • Implenomics

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-03
Primary Completion
2027-01-31
Completion
2028-01-31

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06572774 on ClinicalTrials.gov